Hecht Beth

See Remarks

Hecht Beth has filed 11 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 11 of those filings fall inside the rolling window. Most recent filing: Sep 1, 2026.

On the most recent filing, Hecht Beth is listed as See Remarks at Xeris Biopharma Holdings, Inc. Inside the rolling window, Hecht Beth reported no open-market purchases and 11 open-market sales totaling $1.3M in XERS. The largest disclosed transaction in the window is a sale of 16,666 XERS shares on Sep 1, 2026, worth $141K.

Companies traded

Other insiders at XERS

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.3M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
XERSSale$141KSep 1SEC ↗
XERSSale$134KAug 4SEC ↗
XERSSale$134KJul 2SEC ↗
XERSSale$101KJun 2SEC ↗
XERSSale$104KMay 1SEC ↗
XERSSale$100KApr 3SEC ↗
XERSSale$104KMar 4SEC ↗
XERSSale$124KFeb 2SEC ↗
XERSSale$124KJan 5SEC ↗
XERSSale$117KDec 2SEC ↗
XERSSale$123KNov 13SEC ↗
Showing 1–11 of 11
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Hecht Beth made?

Hecht Beth has filed 11 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.

Which companies does Hecht Beth trade?

Hecht Beth has filed SEC Form 4 disclosures for 1 company, including XERS.

When was Hecht Beth's most recent SEC Form 4 filing?

Hecht Beth's most recent SEC Form 4 filing on Tracefour is dated Sep 1, 2026.

What is Hecht Beth's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Hecht Beth is listed as See Remarks.

What is Hecht Beth's total buy and sell value in the current window?

Inside the rolling retention window, Hecht Beth bought $0 and sold $1.3M based on SEC Form 4 filings.

What was Hecht Beth's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 16,666 XERS shares on 2026-09-01, worth $141K, per SEC Form 4 filings.